Schedule 13G ownership disclosure
CYTOTHERAPEUTICS INC/DE
Security class unavailable
Event date: 2017-01-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,149,438
- Percent of class
- 11.8610%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-000166
- Form type
- SC 13G
- Filer
- Lewkowicz Leon
- CIK
- CIK 1690590
- Filed
- Jan 09, 2017
- Reporting period
- Jan 04, 2017
- Description
- Schedule 13G beneficial ownership